Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

NCT01864772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Interventions

DRUG: Carbo, 5FU, Cetuximab

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou

Collaborators

[object Object]